SIE

211.9

+2.29%↑

AIR.FR

164.8

+2.59%↑

ENR.DE

148.75

+4.13%↑

RHM

1,529.5

+5.52%↑

HO

263.8

+4.52%↑

SIE

211.9

+2.29%↑

AIR.FR

164.8

+2.59%↑

ENR.DE

148.75

+4.13%↑

RHM

1,529.5

+5.52%↑

HO

263.8

+4.52%↑

SIE

211.9

+2.29%↑

AIR.FR

164.8

+2.59%↑

ENR.DE

148.75

+4.13%↑

RHM

1,529.5

+5.52%↑

HO

263.8

+4.52%↑

SIE

211.9

+2.29%↑

AIR.FR

164.8

+2.59%↑

ENR.DE

148.75

+4.13%↑

RHM

1,529.5

+5.52%↑

HO

263.8

+4.52%↑

SIE

211.9

+2.29%↑

AIR.FR

164.8

+2.59%↑

ENR.DE

148.75

+4.13%↑

RHM

1,529.5

+5.52%↑

HO

263.8

+4.52%↑

Search

Krones AG

Atvērts

SektorsRūpniecība

118.6 2.95

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

114.4

Max

120.4

Galvenie mērījumi

By Trading Economics

Ienākumi

-11M

85M

Pārdošana

176M

1.6B

P/E

Sektora vidējais

12.628

57.257

EPS

2.7

Peļņas marža

5.486

Darbinieki

21,133

EBITDA

-42M

100M

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt

Prognoze 12 mēnešiem

+34% upside

Dividendes

By Dow Jones

Nākamie ieņēmumi

2026. g. 8. maijs

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

-708M

3.7B

Iepriekšējā atvēršanas cena

115.65

Iepriekšējā slēgšanas cena

118.6

Ziņu noskaņojums

By Acuity

50%

50%

187 / 405 Rangs Industrials

Tehniskais rādītājs

By Trading Central

Pārliecība

Weak Bullish Evidence

Krones AG Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 31. marts 23:31 UTC

Karstas akcijas

Stocks to Watch: Nike, RH, NCino

2026. g. 31. marts 22:35 UTC

Peļņas

Nike Guides for Sales Declines Ahead as Turnaround Plan Hits Snags -- 2nd Update

2026. g. 1. apr. 00:00 UTC

Iegādes, apvienošanās, pārņemšana

The Year Is Off to the Strongest Start for Big Deals Ever -- WSJ

2026. g. 31. marts 23:50 UTC

Iegādes, apvienošanās, pārņemšana

Nxera Pharma: Partner Centessa Pharmaceuticals to Be Acquired by Lilly >LLY 4565.TO

2026. g. 31. marts 23:43 UTC

Tirgus saruna

Nikkei May Rise on Hopes for Iran War Ending Soon -- Market Talk

2026. g. 31. marts 23:33 UTC

Tirgus saruna
Galvenie ziņu notikumi

Gold Edges Higher on Signs of De-Escalating Middle East Tensions -- Market Talk

2026. g. 31. marts 23:21 UTC

Peļņas

Nike Stock Slides on Tariff Impact Despite Earnings Beat; Turnaround Continues -- Barrons.com

2026. g. 31. marts 23:14 UTC

Tirgus saruna
Peļņas

Nike CEO Says Turnaround is Taking Longer Than He'd Like -- Market Talk

2026. g. 31. marts 23:12 UTC

Tirgus saruna

Aurelia's Cash Flow Strength Highlighted by New Financing Deal -- Market Talk

2026. g. 31. marts 22:36 UTC

Peļņas

China Vanke 2025 Loss Widens >000002.SZ

2026. g. 31. marts 22:36 UTC

Peļņas

China Vanke: Increase in Inventory Impariment Provision Among Factors Weighing On Results>000002.SZ

2026. g. 31. marts 22:36 UTC

Peļņas

China Vanke 2025 Loss CNY88.56B Vs. Loss CNY49.48B >000002.SZ

2026. g. 31. marts 22:36 UTC

Peļņas

China Vanke: Will Take Time to Resolve Issues Caused by High Debt Levels>000002.SZ

2026. g. 31. marts 22:36 UTC

Peļņas

China Vanke 2025 Rev CNY233.43B Vs. CNY343.18B >000002.SZ

2026. g. 31. marts 21:46 UTC

Iegādes, apvienošanās, pārņemšana

Big Drug Companies Hunting for Deals Are Lowering Their Sights -- WSJ

2026. g. 31. marts 21:36 UTC

Tirgus saruna

West African Resources's Costs Higher Than Bull Expected -- Market Talk

2026. g. 31. marts 21:35 UTC

Peļņas

Nike Expects China Sales Down 20% in 4Q, CFO Says

2026. g. 31. marts 21:35 UTC

Peļņas

Nike Expects Modest Growth in North America, Offset by Declines in China, Converse Brand in 4Q, CFO Says

2026. g. 31. marts 21:35 UTC

Peļņas

Nike Forecasts 4Q Sales Down 2% to 4%, CFO Says

2026. g. 31. marts 21:33 UTC

Iegādes, apvienošanās, pārņemšana

Biotechs Are a Healthy Growth Bet Thanks to M&A and New Drugs -- Barrons.com

2026. g. 31. marts 21:33 UTC

Peļņas

Nike Expects Sales Down Low-Single Digits From Now Through End of Calendar Year, CFO Says

2026. g. 31. marts 21:32 UTC

Peļņas

Nike Expects 1Q to Be Final Quarter Where Tariffs Continue to Be Year-Over-Year Headwind to Margins, CFO Says

2026. g. 31. marts 21:28 UTC

Peļņas

Nike Expects to End 4Q With Elevated Inventory, CFO Says

2026. g. 31. marts 21:26 UTC

Peļņas

Nike Increasingly Confident It Will Return to Balanced Growth in North America in Direct, Wholesale Channels, CFO Says

2026. g. 31. marts 21:25 UTC

Peļņas

Nike Expects Supply-Chain Changes to Pay Off Starting in Fiscal 2027, CFO Says

2026. g. 31. marts 21:24 UTC

Tirgus saruna
Peļņas

Nike: Turnaround Plan Progressing at Different Rates -- Market Talk

2026. g. 31. marts 21:22 UTC

Peļņas

Nike CFO Expects Football Training and Basketball Will Return to Growth Over Next Few Quarters

2026. g. 31. marts 21:22 UTC

Peļņas

Nike's Sportswear Business Declined Low-Double Digits in 3Q, CFO Says

2026. g. 31. marts 21:21 UTC

Peļņas

Nike's Digital Channel Still Too Promotional, CFO Says

2026. g. 31. marts 21:20 UTC

Peļņas

Nike CEO: Converse Remains Important to Portfolio

Salīdzinājums

Cenas izmaiņa

Krones AG Prognoze

Cenas mērķis

By TipRanks

34% augšup

Prognoze 12 mēnešiem

Vidējais 153.83 EUR  34%

Augstākais 187 EUR

Zemākais 105 EUR

Pamatojoties uz 7 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Krones AG — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt

7 ratings

6

Pirkt

0

Turēt

1

Pārdot

Tehniskais rādītājs

By Trading Central

132 / N/AAtbalsts un pretestība

Īstermiņā

Weak Bullish Evidence

Vidējā termiņā

Bullish Evidence

Ilgtermiņā

Strong Bullish Evidence

Noskaņojums

By Acuity

187 / 405 Rangs Rūpniecība

Ziņu noskaņojums

Neutral

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Zem vidējā

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Krones AG

Krones AG, together with its subsidiaries, engages in the planning, development, and manufacture of machines and lines for the production, filling, and packaging technology in Germany and internationally. It operates in three segments, Filling and Packaging Technology, Process Technology, and Intralogistics. The Filling and Packaging Technology segment offers machines and lines for stretch blow molders, bottle washing, filling, inspection, labelling, conveying, product packing, palletizing, treatment, technology products, as well as for producing PET containers and converting used plastic bottles into food-grade recycled material. The Process Technology segment supplies machines and lines for producing and processing beer, soft drinks, fruit juices, milk, dairy drinks, and alternative proteins; and provides water treatment solutions. The Intralogistics segment is involved in the planning and design of fully automated warehousing, order-picking and material flow systems with high-speed feeders, conveyors, and automated guided vehicle systems. It also offers complete logistics systems, supply and disposal systems, and custom IT and digitalization solutions that manage and optimize all production processes. The company serves breweries; beverage producers; and companies from the food, chemical, pharmaceutical, and cosmetic industries. Krones AG was founded in 1951 and is headquartered in Neutraubling, Germany.
help-icon Live chat